Healthcare -
Biotechnology - NASDAQ - US
$ 3.69
2.5 %
$ 39.8 M
Market Cap
-2.07
P/E
LTRN - OPERATING INCOME
Operating Income LTRN - Lantern Pharma Inc.
-17.9 M
LAST VALUE
-19.16%
2 YEAR CAGR
-59.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR